Loading…

Patients With Mild Asthma and Concomitant Allergic Rhinitis (AR) Had Better AR and Asthma Treatment Success with Mometasone Furoate Nasal Spray when Compared with Leukotriene Receptor Antagonists, Non-Sedating Anti-Histamines (NSA) and Combinations of NSA and Decongestants

First-year post-therapy outcomes included: AR treatment success (no additional AR medications, increase in office visit rate, or AR-related emergency room/urgent care/hospital visits), asthma treatment success (no exacerbations, controller medication step-up, increased short-acting β2-agonist use,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.AB170-AB170
Main Authors: Navaratnam, P, Reardon, G, Friedman, H.S, Gopalan, G, Krouse, J.H
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:First-year post-therapy outcomes included: AR treatment success (no additional AR medications, increase in office visit rate, or AR-related emergency room/urgent care/hospital visits), asthma treatment success (no exacerbations, controller medication step-up, increased short-acting β2-agonist use, or increased asthma visits), and combined AR/asthma treatment success.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2009.12.667